AGP Wire

AGP

The multi-parameter patient monitoring equipment market is projected to grow from $9.57 billion in 2025 to $10.34 billion in 2026, with North America leading and Asia-Pacific set to grow fastest.

AGP

Global Outbreak Solutions says it is deploying expert teams and hands-on training across the Americas, Africa and Asia to strengthen readiness for animal disease outbreaks and other biosecurity threats.

AGP

The medical health scale market rose to $3.8 billion in 2026 and is projected to hit $5.25 billion by 2030, according to The Business Research Company.

AGP

The global health supplements market is projected to rise from $155.8 billion in 2025 to $243.5 billion by 2035, driven by preventive health awareness, personalized nutrition, e-commerce and new delivery formats.

AGP

The Lyme disease testing market is projected to grow from $10.68 billion in 2025 to $16.46 billion by 2030, driven by rising tick-borne illness cases, wider use of rapid diagnostics and more funding for surveillance.

AGP

The hospital beds market is projected to rise from $4.6 billion in 2025 to $4.99 billion in 2026, then reach $7.11 billion by 2030, as hospitals expand capacity and add smarter patient-care equipment.

AGP

The hospital-acquired infections testing kits market is projected to grow from $4.79 billion in 2025 to about $7.2 billion by 2030 as hospitals expand infection surveillance and adopt faster diagnostics.

AGP

The hospital stretchers market is projected to grow from $2.98 billion in 2025 to $4.29 billion by 2030, driven by rising emergency admissions, more surgical procedures and wider use of powered mobility stretchers.

AGP

The healthcare smart card reader market is projected to nearly double from 2026 to 2030 as hospitals and clinics lean harder into digital records, secure authentication and connected healthcare systems.

AGP

The Business Research Company says the global infectious disease molecular diagnostics market will grow from $32.04 billion in 2026 to $38.77 billion by 2030. The report points to faster adoption of AI tools, point-of-care testing, multiplex…

AGP

The infectious disease diagnostics testing market is projected to grow from $42.24 billion in 2025 to $65.49 billion by 2030, according to The Business Research Company.

AGP

The global infectious disease in vitro diagnostics market is projected to grow from $16.13 billion in 2026 to $21.25 billion by 2030, driven by rising disease burden, molecular testing adoption and pandemic preparedness.

AGP

The implantable remote patient monitoring devices market is projected to grow from $10.26 billion in 2025 to $27.48 billion by 2030, driven by telehealth adoption, chronic disease management and sensor advances.

AGP

Health City Cayman Islands is warning residents and visitors across the Cayman Islands and wider Caribbean to prepare now for hurricane season if they rely on medication, treatment or powered medical devices.

AGP

The home healthcare equipment market is forecast to rise from $37.83 billion in 2025 to $41.25 billion in 2026, then reach $58.15 billion by 2030, as chronic disease, aging populations and telehealth push more care into the home.

AGP

The home health monitoring devices market is projected to rise from $1.42 billion in 2025 to $1.49 billion in 2026, then reach $1.83 billion by 2030, according to The Business Research Company.

AGP

The market for non-invasive cholesterol readers is projected to rise from $1.3 billion in 2025 to $2.63 billion by 2030, driven by cardiovascular disease prevalence, healthcare spending and demand for painless testing.

AGP

The non-invasive ventilators market is projected to grow from $3.05 billion in 2025 to $4.42 billion by 2030, according to The Business Research Company.

AGP

The market for neurology diagnostic and monitoring devices is projected to rise from $9.32 billion in 2025 to $10.19 billion in 2026, with growth tied to aging populations, rising neurological disease rates and better imaging tools.

AGP

The neurophysiology devices and equipment market is projected to grow from $1.76 billion in 2026 to $2.51 billion by 2030, driven by rising neurological disease rates, more point-of-care diagnostics and wider use of portable and wireless systems….